US2016296483A1PendingUtilityA1

Methods and Pharmaceutical Compositions for Treatment of Cystic Fibrosis

27
Assignee: INSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)Priority: Aug 13, 2012Filed: Jun 6, 2016Published: Oct 13, 2016
Est. expiryAug 13, 2032(~6.1 yrs left)· nominal 20-yr term from priority
Inventors:Agathe TarzePascale Fanen
A61P 29/00A61K 45/06A61P 11/12A61K 31/192
27
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a method and compositions for the treatment of cystic fibrosis.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . A method for treating an inflammatory pulmonary disease in a subject in need thereof, comprising the step of administering to said subject sulindac or a sulindac derivative. 
     
     
         3 . (canceled) 
     
     
         4 . The method according to  claim 2  wherein said sulindac or said sulindac derivative is administered in combination with one or more anti-inflammatory agents.

Join the waitlist — get patent alerts

Track US2016296483A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.